State Healthcare Transaction Notice Clocks Compared
A seller can use this chart to identify state notice deadlines that may shape a healthcare transaction's closing schedule. When more than one clock applies, the longest applicable clock, not the average, sets the earliest close.
Compare the seven state notice periods below with the separate federal HSR waiting period, then map the applicable filings with counsel before setting a target close.
Data as of November 21, 2026. Figures are linked to official sources. This free educational resource is not legal advice, is not a filing manual, and does not determine whether any deal must be filed. Laws and thresholds change. Have a healthcare antitrust or transactional attorney map applicable filings before the letter of intent is signed.
Educational note, not legal advice: These clocks are planning references, not a determination that a notice is required for a particular practice or transaction. Confirm current rules with counsel.
How to read the clocks
State notice deadlines below say how far before closing or the effective date a notice must be filed. HSR is different. Its standard initial period is a wait after complete federal filings are received. A deadline is a minimum filing lead time, not a prediction of the full review duration. Tolling, requests for information, extensions, or a separate review can affect timing.
The bars show official minimum notice lead times, not the full length of any later review. HSR is a waiting period after complete filings, so it is not drawn on the same axis. Figures as of November 21, 2026, from the official sources in the table.
Text version
- Oregon HCMO: 180 calendar days before the proposed effective or closing date
- California OHCA: 90 calendar days before the closing date
- Indiana: 90 days before the merger or acquisition
- Washington: 60 days before the effective date
- Massachusetts: 60 days before the proposed effective date
- New York: 30 days, and DOH has said the clock starts when the filing is complete
- Illinois: 30 days before closing or the effective date (a simultaneous HSR copy can satisfy notice when the deal is HSR-reportable)
- Federal HSR, shown separately: 30-day initial waiting period after complete filings (15 days for cash tender offers and certain bankruptcy sales)
HealthcareInvestmentBanking.com chart from official state and FTC sources, dated November 21, 2026
| Jurisdiction | Notice lead time | Clock starts or timing note | Official source |
|---|---|---|---|
| Oregon HCMO | 180 calendar days | Before proposed effective or closing date | OHA FAQ |
| California OHCA | 90 calendar days | Before closing date | HCAI FAQ |
| Indiana | 90 days | Before merger or acquisition date | Indiana AG FAQ |
| Washington | 60 days | Before effective date | RCW 19.390.030 |
| Massachusetts | 60 days | Before proposed effective date | Massachusetts HPC |
| New York | 30 days | DOH says clock starts when filing is complete | New York DOH |
| Illinois | 30 days | Before closing or effective date. A simultaneous HSR copy can satisfy notice for HSR-reportable deals | Illinois AG |
HSR, shown separately: The standard initial federal wait is 30 calendar days after the agencies receive complete filings from the required parties. The wait is 15 days for cash tender offers and certain bankruptcy sales. The FTC premerger notification program explains the program. HSR-reportability is not assumed here. For 2026, the transaction threshold is more than $133.9 million, but transactions above that amount and not above $535.5 million also face a size-of-person test unless exempt. Transactions above $535.5 million are reportable regardless of size of person unless exempt. Counsel must assess the actual parties, holdings, valuation, and exemptions.
Planning example: California and HSR
Assume a transaction involves a California health care entity or noticing entity that meets a current notice rule, and the transaction also requires an HSR filing. The seller and buyer should not count from signing. California requires its Notice at least 90 calendar days before closing. HSR's standard initial wait runs 30 calendar days after complete filings are received. On those stated periods alone, the California advance notice is longer, so the parties would need to file early enough to meet that 90-day lead time while also satisfying the federal wait.
That is a baseline illustration, not a closing-date guarantee. If a second request issues, HSR adds a further wait after substantial compliance, ordinarily 30 days, or 10 days for cash tender offers. California may conduct a CMIR, toll its review while information is outstanding, and extend certain review periods. Do not add these periods mechanically: their triggers differ, and the facts do not establish that every review applies. The transaction agreement and closing conditions should account for the actual process.
Use the healthcare M&A process and timeline guide alongside the M&A timeline infographic. A practice sale may also involve clinical, billing, and compliance diligence. See what buyers test in compliance diligence.
After-filing review add-ons
The filing lead time is only one part of the schedule. The table lists additional review steps supplied by the official sources. The periods below are not extra bar lengths to stack automatically onto the notice deadline. Some periods run from a complete filing or a specific determination, and some can be tolled.
| Jurisdiction | Review add-on |
|---|---|
| HSR | 30-day initial wait after complete filings, or 15 days for cash tender offers and certain bankruptcy sales. A second request adds a post-substantial-compliance wait of 30 days ordinarily, or 10 days for cash tender offers. |
| California | Initial review up to 45 days after a complete notice, with a CMIR determination by day 60. If a CMIR proceeds, completion is within 90 days from its final determination, with one possible 30-day extension. A preliminary report is followed by 10 business days for comments and a final report within 15 days after the comment period closes. Tolling may apply. |
| Oregon | Preliminary review within 30 calendar days of a complete notice. If comprehensive review is required, completion is within 180 calendar days of notice filing, subject to tolling or extension. |
| Indiana | AG review within 45 days after a conforming notice. The reporting statute does not extend the 90-day notice period. |
| Washington | The AG may request information within 30 days of notice. If requested, the transaction may not proceed until 30 days after substantial compliance is certified. |
| Illinois | The AG may request information within 30 days of notice. If requested, the transaction may not proceed until 30 days after substantial compliance. |
| New York | Completeness can delay the start of the 30-day period. DOH posts a transaction summary and related information during the period. |
| Massachusetts | The HPC may conduct a cost and market impact review. No review duration is stated here. Check the current form and regulations. |
Scope and deal preparation
These seven states are examples with official clocks as of the page date. This is not a 50-state survey. Other states have or are adding healthcare transaction notice laws. The transaction's footprint can include the seller's locations, patient residence, and the buyer's existing operations. Ask counsel to identify each potentially relevant state and confirm whether the parties, transaction type, revenue, assets, or control change meet its current coverage test.
For example, California has revenue and asset tests and additional categories. Oregon's materiality test uses party revenue averaged over the three most recent fiscal years. Indiana's $10 million asset test counts the transacting parties' combined total assets, not just the deal price. New York examines specified health care entities and a $25 million or more increase in total gross in-state revenues. Massachusetts directs filers to its current form and regulations for the applicable threshold. These are not interchangeable tests, so do not infer coverage from the clock table alone.
Ownership and management arrangements can matter as much as the purchase agreement. New York includes some MSO management agreements that transfer control. Investors considering an MSO or professional entity structure can review the MSO guide and healthcare deal structures guide. Owners preparing to sell can use the physician practice sale guide. Investors assessing a platform or add-on can see private equity physician roll-ups.
Before signing a letter of intent, put filing responsibility, cooperation, information delivery, regulatory conditions, and outside dates into the deal plan. Tie the close estimate to the longest applicable clock and any review path that is actually triggered. Revisit it when the filing is complete, an agency requests information, or the parties change the structure.
Educational note, not legal advice: Use this comparison to frame questions and organize timing. It is not a filing manual or legal conclusion. Have healthcare antitrust or transactional counsel confirm current law, coverage, filing triggers, and the schedule for the specific deal.
Questions owners and investors ask
Does every practice sale need an HSR filing?
No. Many standalone physician-practice sales fall below the federal transaction threshold and may not need HSR. Other tests and exemptions also matter. Platform add-ons, hospital system deals, and larger recaps may require analysis even when a small practice sale would not.
Which clock controls the close?
When multiple applicable pre-close periods overlap, plan around the longest applicable clock and any required review process. The start points differ, so counsel should map each trigger. Comparing the day counts alone is not enough.
When does the HSR period start?
The standard initial wait starts after the agencies receive complete filings from the required parties. It does not start on the signing date.
Can a state review change the schedule?
Yes. Some reviews can be paused or extended, and some states have additional-information steps. The effect depends on the particular rule, request and filing status.
Is this a complete state survey?
No. It compares seven states only. Have counsel check the jurisdictions connected to the parties, facilities, and patients and recheck rules in force when the transaction is planned.
Sources
- FTC Premerger Notification Program and 2026 HSR thresholds and fees
- California HCAI OHCA FAQs and approved CMIR regulations
- Oregon HCMO FAQ and HCMO guidance
- Washington RCW 19.390.030 and Washington AG premerger notifications
- New York DOH material transactions and DOH program presentation
- Massachusetts HPC material change notices and 958 CMR 7.00
- Indiana AG reporting FAQ and Indiana Code article 25-1-8.5
- Illinois AG healthcare antitrust page and 740 ILCS 10/7.2a